OHSU Knight Cancer Institute
3 clinical trials · 3 recruiting · OTHER
Trials by OHSU Knight Cancer Institute
RECRUITINGNCT06673095
Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial
This clinical trial compares the effect of a narrow surgical excision (removal) to a wide excision for the treatment of adults with invasive cutaneous melanoma. Currently the...
Sponsor: OHSU Knight Cancer InstituteEnrolling: 10001 location
Clinical Stage IA Cutaneous Melanoma AJCC v8Clinical Stage IB Cutaneous Melanoma AJCC v8
RECRUITINGPhase 1NCT04659616
Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia
This phase I trial identifies the best dose and clinical benefit of giving pemigatinib following standard induction chemotherapy in patients with newly diagnosed acute myeloid...
Sponsor: OHSU Knight Cancer InstituteEnrolling: 322 locations
Acute Myeloid Leukemia
RECRUITINGPhase 2NCT03270059
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
This phase II trial studies how well gadolinium and ferumoxytol magnetic resonance imaging (MRI) work in diagnosing patients with abnormalities in the central nervous system....
Sponsor: OHSU Knight Cancer InstituteEnrolling: 1501 location
Central Nervous System NeoplasmCranial Nerve DisorderMetastatic Malignant Neoplasm in the Brain